NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagy
- Resource Type
- Article
- Source
- In
European Journal of Pharmacology 15 March 2024 967 - Subject
- Language
- ISSN
- 0014-2999